What is TENOFOVIR DISOPROXIL FUMARATE used for?

TENOFOVIR DISOPROXIL FUMARATE (brand name Tenofovir Disoproxil Fumarate) is a Other indicated for BIKTARVY ®, COMPLERA ®, DESCOVY ®.

How does TENOFOVIR DISOPROXIL FUMARATE work?

TENOFOVIR DISOPROXIL FUMARATE works through the following mechanism: 12.1 Mechanism of Action Tenofovir disoproxil fumarate is an antiviral drug [See Microbiology ( 12.4 )]..

What are the most common side effects of TENOFOVIR DISOPROXIL FUMARATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for TENOFOVIR DISOPROXIL FUMARATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is TENOFOVIR DISOPROXIL FUMARATE the same as Tenofovir Disoproxil Fumarate?

Tenofovir Disoproxil Fumarate is a brand name for TENOFOVIR DISOPROXIL FUMARATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

TENOFOVIR DISOPROXIL FUMARATE

Other

Brand names: Tenofovir Disoproxil Fumarate

Pregnancy: Category BOral

Mechanism of Action

12.1 Mechanism of Action Tenofovir disoproxil fumarate is an antiviral drug [See Microbiology ( 12.4 )].

Indications

BIKTARVY ®

COMPLERA ®

DESCOVY ®

GENVOYA ®

ODEFSEY ®

STRIBILD ®

Contraindications

• 4 CONTRAINDICATIONS None. None. (4)

FDA Warnings

5 WARNINGS AND PRECAUTIONS • New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome
In patients at risk for renal dysfunction, assess estimated creatinine clearance, serum phosphorus, urine glucose, and urine protein before initiating treatment with tenofovir disoproxil fumarate tablets and periodically during treatment
5) • Decreases in bone mineral density (BMD): Consider assessment of BMD in patients with a history of pathologic fracture or other risk factors for osteoporosis or bone loss
In patients at risk of renal dysfunction, including patients who have previously experienced renal events while receiving HEPSERA ®, it is recommended that estimated creatinine clearance, serum phosphorus, urine glucose, and urine protein be assessed prior to initiation of tenofovir disoproxil fumarate tablets, and periodically during tenofovir disoproxil fumarate tablets therapy

Known Side Effects

1 documented side effects by frequency

Anxiety

1-10%

Community Discussions

No community discussions found for TENOFOVIR DISOPROXIL FUMARATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → TENOFOVIR DISOPROXIL FUMARATE openFDA label JSON → TENOFOVIR DISOPROXIL FUMARATE FAERS adverse-event reports → TENOFOVIR DISOPROXIL FUMARATE ClinicalTrials.gov → completed Phase 2+ trials of TENOFOVIR DISOPROXIL FUMARATE

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Oral